Project Scope
The goal is to deliver a user-friendly, noninvasive, and portable device that can accurately measure and display the user’s transient glucose concentration in the blood stream. The transient nature of glucose concentrations means that it changes over time due to bodily activities such as eating and exercising. To measure the transient glucose concentration, the method of measuring must have no time lag, as in an accurate reading for that moment in time. The users will be population of adults with diabetes mellitus in the United States, and user-friendly means that the majority of users are able to operate the device with minimal effort, practice, and error. As a non-invasive device, it can measure glucose without employing implanted parts or puncturing the skin regularly. It will be transportable to and usable in domestic and work settings, weighing less than 5 lbs and smaller than 0.25 cubic feet. Finally, device is accurate within 10% of the commercially-available methods at least 95% of the time for blood glucose levels from 50 mg/dL to 400 mg/dL.
● Device does not require implanted parts or physically puncturing the user daily
● Device gives results in a reasonable time frame (within 1 minute)
● Device displays blood glucose in standard units (mg glucose/dL blood)
● Device warns user on detection of dangerous glucose levels (>200mg/dL or <70mg/dL)
● Device should be lighter than 20 N and smaller than 200 cm3
● Device contains internal power for one month of testing
● Device should be accurate within 10% of the commercially-available methods at least 95% of the time
The goal is to deliver a user-friendly, noninvasive, and portable device that can accurately measure and display the user’s transient glucose concentration in the blood stream. The transient nature of glucose concentrations means that it changes over time due to bodily activities such as eating and exercising. To measure the transient glucose concentration, the method of measuring must have no time lag, as in an accurate reading for that moment in time. The users will be population of adults with diabetes mellitus in the United States, and user-friendly means that the majority of users are able to operate the device with minimal effort, practice, and error. As a non-invasive device, it can measure glucose without employing implanted parts or puncturing the skin regularly. It will be transportable to and usable in domestic and work settings, weighing less than 5 lbs and smaller than 0.25 cubic feet. Finally, device is accurate within 10% of the commercially-available methods at least 95% of the time for blood glucose levels from 50 mg/dL to 400 mg/dL.
● Device does not require implanted parts or physically puncturing the user daily
● Device gives results in a reasonable time frame (within 1 minute)
● Device displays blood glucose in standard units (mg glucose/dL blood)
● Device warns user on detection of dangerous glucose levels (>200mg/dL or <70mg/dL)
● Device should be lighter than 20 N and smaller than 200 cm3
● Device contains internal power for one month of testing
● Device should be accurate within 10% of the commercially-available methods at least 95% of the time